54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 07
00:32 UTC
|
CAT
Caterpillar
|
◎ Target | Michael Shlisky ★★☆☆☆ #2833 | Neutral | $845.00→ $882.00+4.4% |
|
Aug 07
00:32 UTC
|
CAT
Caterpillar
|
◎ Target | Adam Seiden ★★★☆☆ #1582 | Equal Weight | $800.00→ $900.00+12.5% |
|
Aug 07
00:32 UTC
|
CARL
Carlsmed
|
◎ Target | Richard Newitter ★★★★☆ #460 | Buy | $18.00→ $20.00+11.1% |
|
Aug 07
00:32 UTC
|
BXC
BlueLinx
|
◎ Target | Kurt Yinger ★★☆☆☆ #2336 | Neutral | $65.00→ $84.00+29.2% |
|
Aug 07
00:32 UTC
|
BXC
BlueLinx
|
◎ Target | Reuben Garner ★★☆☆☆ #2457 | Buy | $75.00→ $83.00+10.7% |
|
Aug 07
00:32 UTC
|
BWA
BorgWarner
|
◎ Target | Andrew Percoco ★★☆☆☆ #2697 | Equal Weight | $67.00→ $71.00+6.0% |
|
Aug 07
00:32 UTC
|
BWA
BorgWarner
|
◎ Target | Itay Michaeli ★★☆☆☆ #2791 | Hold | $67.00→ $68.00+1.5% |
|
Aug 07
00:32 UTC
|
BV
BrightView
|
◎ Target | Toni Kaplan ★★★★☆ #542 | Equal Weight | $14.00→ $12.50-10.7% |
|
Aug 07
00:32 UTC
|
BTDR
Bitdeer Technologies Group
|
◎ Target | Mark Palmer ★★★★☆ #828 | Buy | $27.00→ $22.00-18.5% |
|
Aug 07
00:32 UTC
|
BROS
Dutch Bros
|
◎ Target | Matt Curtis ★★★☆☆ #2103 | Buy | $90.00→ $85.00-5.6% |
|
Aug 07
00:32 UTC
|
BROS
Dutch Bros
|
◎ Target | Logan Reich ★★★★☆ #970 | Outperform | $75.00→ $70.00-6.7% |
|
Aug 07
00:32 UTC
|
BREE
Breedon Group
|
◎ Target | firm only | Neutral | GBX 310→ GBX 330+6.5% |
|
Aug 07
00:32 UTC
|
BR
Broadridge Financial Solutions
|
◎ Target | James Faucette ★★★☆☆ #1134 | Equal Weight | $169.00→ $176.00+4.1% |
|
Aug 07
00:32 UTC
|
BOY
Bodycote
|
◎ Target | firm only | Sec→ r perform | GBX 750→ GBX 950+26.7% |
|
Aug 07
00:32 UTC
|
BMBL
Bumble
|
◎ Target | Alexandra Steiger not yet tracked | Neutral | $5.00→ $3.50-30.0% |
|
Aug 07
00:32 UTC
|
BLMN
Bloomin' Brands
|
◎ Target | John Glass not yet tracked | Equal Weight | $8.00→ $12.00+50.0% |
|
Aug 07
00:32 UTC
|
BLLN
Billiontoone
|
◎ Target | Mark Massaro ★★★★★ #173 | Buy | $142.00→ $130.00-8.5% |
|
Aug 07
00:32 UTC
|
BLLN
Billiontoone
|
◎ Target | Casey Woodring ★★★★★ #14 | Overweight | $145.00→ $130.00-10.3% |
|
Aug 07
00:32 UTC
|
BLDP
Ballard Power Systems
|
◎ Target | firm only | Sec→ r Perform | C$4.75→ C$4.50-5.3% |
|
Aug 07
00:32 UTC
|
BLBD
Blue Bird
|
◎ Target | Michael Shlisky ★★☆☆☆ #2833 | Buy | $86.00→ $91.00+5.8% |
|
Aug 07
00:32 UTC
|
BLBD
Blue Bird
|
◎ Target | Gregory Lewis ★☆☆☆☆ #3072 | Buy | $80.00→ $95.00+18.8% |
|
Aug 07
00:32 UTC
|
BCRX
BioCryst Pharmaceuticals
|
◎ Target | Brian Abrahams ★★★☆☆ #2227 | Outperform | $14.00→ $13.00-7.1% |
|
Aug 07
00:32 UTC
|
BCRX
BioCryst Pharmaceuticals
|
◎ Target | Laura Chico ★★☆☆☆ #2653 | Outperform | $21.00→ $20.00-4.8% |
|
Aug 07
00:32 UTC
|
BAM
Brookfield Asset Management
|
◎ Target | firm only | Neutral | $48.00→ $55.00+14.6% |
|
Aug 07
00:32 UTC
|
BAM
Brookfield Asset Management
|
◎ Target | firm only | Outperform | $69.00→ $70.00+1.4% |
|
Aug 07
00:32 UTC
|
BAM
Brookfield Asset Management
|
◎ Target | firm only | Sec→ r Outperform | $57.00→ $59.00+3.5% |
|
Aug 07
00:32 UTC
|
BA
Boeing
|
◎ Target | Ivan Feinseth ★★☆☆☆ #2680 | Buy | $295.00→ $305.00+3.4% |
|
Aug 07
00:32 UTC
|
AXON
Axon Enterprise
|
◎ Target | Tim Long ★★★☆☆ #1976 | Overweight | $523.00→ $688.00+31.5% |
|
Aug 07
00:32 UTC
|
AXON
Axon Enterprise
|
◎ Target | Andrew Spinola ★★★☆☆ #1636 | Neutral | $440.00→ $600.00+36.4% |
|
Aug 07
00:32 UTC
|
AXON
Axon Enterprise
|
◎ Target | Meta Marshall ★★★☆☆ #1570 | Overweight | $600.00→ $640.00+6.7% |
|
Aug 07
00:32 UTC
|
AXON
Axon Enterprise
|
◎ Target | James Fish ★★★☆☆ #1704 | Overweight | $724.00→ $732.00+1.1% |
|
Aug 07
00:32 UTC
|
AVT
Avnet
|
◎ Target | William Stein ★★☆☆☆ #2647 | Buy | $95.00→ $110.00+15.8% |
|
Aug 07
00:32 UTC
|
ASH
Ashland
|
◎ Target | Steven Haynes ★★★☆☆ #1267 | Equal Weight | $58.00→ $78.00+34.5% |
|
Aug 07
00:32 UTC
|
ARWR
Arrowhead Pharmaceuticals
|
◎ Target | Patrick R. Trucchio not yet tracked | Buy | $115.00→ $120.00+4.3% |
|
Aug 07
00:32 UTC
|
ARQT
Arcutis Biotherapeutics
|
◎ Target | Serge Belanger ★★★☆☆ #1891 | Buy | $36.00→ $40.00+11.1% |
|
Aug 07
00:32 UTC
|
ARQT
Arcutis Biotherapeutics
|
◎ Target | Vikram Purohit ★★★☆☆ #1279 | Overweight | $34.00→ $38.00+11.8% |
|
Aug 07
00:32 UTC
|
ARQT
Arcutis Biotherapeutics
|
◎ Target | Seamus Fernandez ★★★☆☆ #1859 | Buy | $35.00→ $38.00+8.6% |
|
Aug 07
00:32 UTC
|
AROC
Archrock
|
◎ Target | Michael Blum ★★☆☆☆ #2323 | Overweight | $43.00→ $40.00-7.0% |
|
Aug 07
00:32 UTC
|
ARDT
Ardent Health
|
◎ Target | David MacDonald not yet tracked | Buy | $12.00→ $13.00+8.3% |
|
Aug 07
00:32 UTC
|
ARDT
Ardent Health
|
◎ Target | Jason Cassorla ★★★★☆ #441 | Buy | $13.00→ $14.00+7.7% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Eric Sheridan ★★★☆☆ #1710 | Neutral | $585.00→ $465.00-20.5% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Alicia Reese ★★★☆☆ #1686 | Outperform | $640.00→ $610.00-4.7% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Mike Hickey ★★☆☆☆ #2698 | Buy | $775.00→ $500.00-35.5% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Clark Lampen ★★☆☆☆ #2453 | Buy | $640.00→ $574.00-10.3% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Bernie McTernan ★★☆☆☆ #2452 | Buy | $700.00→ $500.00-28.6% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Omar Dessouky ★★★☆☆ #1312 | Buy | $705.00→ $430.00-39.0% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Matthew Swanson ★★★☆☆ #1014 | Outperform | $700.00→ $575.00-17.9% |
|
Aug 07
00:32 UTC
|
APP
AppLovin
|
◎ Target | Matthew Cost ★★☆☆☆ #2372 | Overweight | $720.00→ $650.00-9.7% |
|
Aug 07
00:32 UTC
|
APLD
Applied Digital
|
◎ Target | Stephen Byrd ★☆☆☆☆ #3160 | Equal Weight | $36.50→ $37.50+2.7% |
|
Aug 07
00:32 UTC
|
APD
Air Products and Chemicals
|
◎ Target | Arun Viswanathan ★★★☆☆ #1251 | Outperform | $358.00→ $360.00+0.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.